Sanofi (SNYNF) Operating Expenses (2009 - 2025)

Sanofi (SNYNF) has 18 years of Operating Expenses data on file, last reported at -$4.9 billion in Q1 2026.

• Quarterly Operating Expenses fell 12.86% year-over-year to -$4.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$46.7 billion (down 42.55% YoY) and the FY2025 annual result came in at $21.6 billion, up 12.27% from the prior year.
• Operating Expenses rose to -$4.9 billion in Q1 2026 per SNYNF's latest filing, from -$21.6 billion in the prior quarter.
• The five-year high for Operating Expenses was -$4.3 billion in Q1 2025, with the low at -$21.6 billion in Q4 2025.
• Average Operating Expenses over 5 years is -$8.3 billion, with a median of -$4.9 billion recorded in 2026.
• Year-over-year, Operating Expenses grew 24.0% in 2022 and plunged 229.95% in 2025.
• Sanofi's Operating Expenses stood at -$10.0 billion in 2022, then sank by 77.76% to -$17.7 billion in 2023, then fell by 8.38% to -$19.2 billion in 2024, then decreased by 12.27% to -$21.6 billion in 2025, then jumped by 77.23% to -$4.9 billion in 2026.
• Business Quant data shows SNYNF's Operating Expenses at -$4.9 billion in Q1 2026, -$21.6 billion in Q4 2025, and -$15.1 billion in Q3 2025.